CME Group's Altman Z-score is 0.59 and sits in the distress zone, below the model's threshold of 1.10, which raises near-term solvency attention. The company has grown revenue and net income across recent annual filings: revenue compounded at 9.11% a year (CAGR, compound annual growth rate) and net income at 14.81% a year. Latest annual revenue rose 6.4% and net income rose 15.5%, and the most recent quarter reported $1.04B in net income with a QoQ (quarter-over-quarter) decline of 0.5%. Assets cover liabilities 1.17 times, a thin cushion, and the Piotroski F-Score of 3 on a 0 to 9 quality scale indicates low earnings-quality signals. Net margin of 62.5% is unusually high for Financials, reflecting exchange and data-licensing economics, and the price-to-earnings ratio of 26.25 is approximately in line with the S&P 500 average. The next earnings report must show whether operating cash flow and balance-sheet trends lift the Altman Z-score above the distress threshold or whether solvency risk persists.